APR 20, 2016 2:56 PM PDT

New Treatment for Atherosclerosis Reduces Side Effects

WRITTEN BY: Kara Marker
For atherosclerosis patients who experience a wide range of side effects to cholesterol-lowering drugs, an alternate option would be life-changing. Although stemming from less than normal means, scientists from the University of Bonn have spent the last six years developing just the right alternate option.
 
Atherosclerosis is a form of heart disease where plaque buildup inside of the blood vessels limits the heart’s ability to pump oxygen and nutrients through the blood to the body’s tissues. Plaque is made up of fat, cholesterol, calcium, and other components that can come from a person’s diet (National Heart, Lung, and Blood Institute).
 
Current drugs for lowering cholesterol to treat atherosclerosis include statins, cholesterol absorption inhibitors, resins, and lipid-lowering therapies (American Heart Association). These drugs work in different way to reduce the amount of cholesterol clogging the blood vessels during atherosclerosis. For example, statins work by preventing formation of cholesterol in the liver.
 
Plaque inhibiting flow of blood in a vessel
 
A rare disease affecting twin females involved inhibiting their cells’ ability to remove cholesterol. In 2010, their mother pondered whether the drugs used to treat their condition, which cleared cholesterol crystals from cells, would be applicable to heart disease. Scientists from the University of Bonn were equally curious after the theory was brought to their attention, and the soon-to-be six-year study began.
 
With the study finally completed and published in Science Translational Medicine, scientists now introduce a drug called cyclodextrin, fresh from both mice and human tissue studies.
 
Cyclodextrin works by dissolving cholesterol crystals so they can more easily be removed by the body, plus the drug reduces the inflammatory response mounted by the immune system to reduce inflammation surrounding blood vessel walls.
 
Mice were fed a cholesterol-rich diet before receiving experimental cyclodextrin, and the drug both prevented future plaque formation as well as reduced existing plaque. Similarly, in human tissue, plaque biopsies obtained from human carotid arteries, researchers saw the removal of cholesterol as well as a “reprogramming” of macrophages to lessen their response to inflammation. With some macrophage activity freed up, these immune cells were able to contribute to the cause by picking up and ridding the vessels of cholesterol.
 
Next up? Funding for clinical trials in humans. Researchers from the University of Bonn are hopeful that cyclodextrin could be the next cholesterol-reducing drug on the market, producing fewer and less severe side effects than other medications.
 
 
Source: The Norwegian University of Science and Technology
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 29, 2020
Drug Discovery & Development
Cycling Molecules into Drug Candidates
SEP 29, 2020
Cycling Molecules into Drug Candidates
Statistics show that just 1 in 5,000 drug candidates ever makes it from the lab to the pharmacy. In a process that can t ...
OCT 09, 2020
Cannabis Sciences
Older Adults Use Cannabis for Common Health Problems
OCT 09, 2020
Older Adults Use Cannabis for Common Health Problems
Researchers from the University of California San Diego have found that older adults tend to use cannabis for medical pu ...
OCT 19, 2020
Cancer
Using qPCR to Diagnose Common Cancer Mutations in Lung Cancer
OCT 19, 2020
Using qPCR to Diagnose Common Cancer Mutations in Lung Cancer
Cancer is a disease characterized by DNA mutations. These mutations, while sometimes small, can cause havoc in a cell&rs ...
OCT 17, 2020
Cell & Molecular Biology
Fat Droplets in Cells Help the Immune System Fight Infection
OCT 17, 2020
Fat Droplets in Cells Help the Immune System Fight Infection
Scientists have found that our immune system has a surprising helper: droplets of fat that sit inside cells.
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
OCT 25, 2020
Microbiology
Over Time, Plague Infections Spread Faster
OCT 25, 2020
Over Time, Plague Infections Spread Faster
From the time of the Black Death, around 1348 and the Great Plague of 1665, epidemics of plague occurred in Europe. Rese ...
Loading Comments...